financetom
Business
financetom
/
Business
/
GameStop Unusual Options Activity For June 21
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GameStop Unusual Options Activity For June 21
Jun 21, 2024 9:34 AM

Deep-pocketed investors have adopted a bullish approach towards GameStop ( GME ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GME usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for GameStop ( GME ). This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 54% leaning bullish and 36% bearish. Among these notable options, 2 are puts, totaling $132,333, and 9 are calls, amounting to $573,410.

Predicted Price Range

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $125.0 for GameStop ( GME ), spanning the last three months.

Volume & Open Interest Development

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in GameStop's ( GME ) options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to GameStop's ( GME ) substantial trades, within a strike price spectrum from $10.0 to $125.0 over the preceding 30 days.

GameStop Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
GME CALL TRADE BULLISH 06/21/24 $4.3 $4.1 $4.3 $21.00 $216.7K 4.0K 9
GME CALL TRADE BULLISH 07/19/24 $4.4 $4.35 $4.4 $25.00 $88.0K 14.3K 17
GME PUT SWEEP NEUTRAL 07/19/24 $16.8 $15.85 $16.33 $40.00 $68.5K 715 5
GME PUT SWEEP BULLISH 06/28/24 $16.0 $14.7 $15.17 $40.00 $63.7K 689 11
GME CALL SWEEP BEARISH 06/28/24 $1.65 $1.57 $1.58 $26.00 $56.0K 3.4K 2.3K

About GameStop

GameStop Corp ( GME ) is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. GameStop ( GME ) sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop ( GME ), EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States.

In light of the recent options history for GameStop ( GME ), it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is GameStop Standing Right Now?

With a volume of 9,434,153, the price of GME is down -3.37% at $24.73.

RSI indicators hint that the underlying stock may be approaching overbought.

Next earnings are expected to be released in 75 days.

What Analysts Are Saying About GameStop

Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $11.0.

An analyst from Wedbush persists with their Underperform rating on GameStop ( GME ), maintaining a target price of $11.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest GameStop ( GME ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NetApp, Amazon Web Services Collaborate on Cloud-Based Data Services
NetApp, Amazon Web Services Collaborate on Cloud-Based Data Services
Sep 22, 2024
10:40 AM EDT, 09/19/2024 (MT Newswires) -- NetApp ( NTAP ) said Thursday it has signed a strategic collaboration deal with Amazon.com's ( AMZN ) Amazon Web Services to deliver performance and scalability for data workloads. The collaboration is expected to accelerate generative AI efforts, streamline transactions, and deliver CloudOps value for customers, the data infrastructure company said. Price: 120.99,...
Snap Unusual Options Activity For September 19
Snap Unusual Options Activity For September 19
Sep 22, 2024
Deep-pocketed investors have adopted a bullish approach towards Snap , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SNAP usually suggests something big is about to happen. We gleaned this information from our observations today...
Renovaro, PersonalAIze Collaborate to Develop AI Platform for Early Disease Detection
Renovaro, PersonalAIze Collaborate to Develop AI Platform for Early Disease Detection
Sep 22, 2024
10:37 AM EDT, 09/19/2024 (MT Newswires) -- Renovaro's ( RENB ) RenovaroCube unit and PersonalAIze said Thursday that they are collaborating to develop, validate and commercialize Cube's artificial intelligence platform for early detection of cancer and other diseases. The partnership will provide services to artificial intelligence companies and healthcare systems, according to the companies. Financial terms of the collaboration were...
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
Sep 22, 2024
* Hung jury in latest Zantac cancer trial in Chicago * Boehringer Ingelheim only defendant after settlements with GSK, Pfizer ( PFE ) * FDA pulled Zantac in 2020 over NDMA carcinogen concerns (Updates Sept 18 story with statement from Boehringer Ingelheim in paragraph 5) By Brendan Pierson Sept 18 (Reuters) - The latest trial over claims that the discontinued...
Copyright 2023-2026 - www.financetom.com All Rights Reserved